Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Postgraduate Medical Journal 2006;82:220-223; doi:10.1136/pgmj.2005.037051
Copyright © 2006 The Fellowship of Postgraduate Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sivakumar, R
Right arrow Articles by Khan, S A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sivakumar, R
Right arrow Articles by Khan, S A

ORIGINAL ARTICLE

Utility of N terminal pro brain natriuretic peptide in elderly patients

R Sivakumar 1, D Wellsted 2, K Parker 1, M Lynch 1, P Ghosh 1, S A Khan 1

1 Lister Hospital, Stevenage, UK
2 HRDSU, University of Hertfordshire, UK

Correspondence to:
Correspondence to:
Dr S A Khan
Strathmore Wing, Lister Hospital, Stevenage SG1 4AB, UK; shahidAK{at}aol.com

Objective: To evaluate the utility of N terminal pro brain natriuretic peptide (NT-proBNP) as a diagnostic marker for diastolic dysfunction or failure, systolic dysfunction, and significant valve disorders in patients over 75 years.

Design: Cohort study.

Setting: Outpatient echocardiography service in a district general hospital.

Participants: 100 consecutive patients.

Main outcome measures: Sensitivity, specificity, positive predictive values, negative predictive values, and area under receiver operating characteristic curve for NT-proBNP assay in the diagnosis of left ventricular diastolic dysfunction or failure, systolic dysfunction, and significant valve disorders.

Results: For diagnosis of systolic dysfunction NT-proBNP level of 424 pg/ml had a sensitivity of 96%, specificity of 45%, positive predictive value of 36%, and negative predictive value of 96%. The area under the curve was 0.71 (95% confidence intervals: 0.69 to 0.89). In valve heart disease, level of 227 pg/ml had sensitivity of 91%, specificity of 43%, positive predictive value of 40%, and negative predictive value of 92%. Patients with diastolic dysfunction/failure had lower plasma concentrations.

Conclusions: This study showed that NT-proBNP had excellent negative predictive value for systolic dysfunction and significant valve disorders in very elderly patients. It increased significantly in systolic dysfunction, valve heart disease, and atrial fibrillation. NT-proBNP is not useful in the diagnosis of diastolic dysfunction or diastolic heart failure using standard echocardiography criteria.


Abbreviations: NT-proBNP, N terminal pro brain natriuretic peptide; AUC, area under curve; LV, left ventricular; LA, left atrial; DT, deceleration time; IVRT, isovolumetric relaxation time; ROC, receiver operating characteristic curve

Keywords: heart failure; diastolic failure; valve heart disease; NT pro-BNP







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 The Fellowship of Postgraduate Medicine